Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Deloitte
Baxter
Daiichi Sankyo
Julphar
Chinese Patent Office
US Army
UBS

Generated: February 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OLOPATADINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Olopatadine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00331500 Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis Completed Alcon Research Phase 3 The purpose of this study is to demonstrate that Olopatadine 0.2% is superior to vehicle in the treatment of the signs and symptoms associated with allergic conjunctivitis or rhinoconjunctivitis.
NCT00389025 Mast-Cell Stabilizing Effects of Olopatadine Completed Alcon Research Phase 4 To assess the effects of olopatadine of the release of mast cell histamine
NCT00489398 Comparison of CL Wear Between Two Allergy Drops Withdrawn Merck Sharp & Dohme Corp. Phase 4 Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
NCT00489398 Comparison of CL Wear Between Two Allergy Drops Withdrawn Hom, Milton M., OD, FAAO Phase 4 Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
NCT00578331 Safety Study of Olopatadine Nasal Spray Completed Alcon Research Phase 3 The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis.
NCT00578929 Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients Completed Alcon Research Phase 3 A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis.
NCT00609128 Allergic Eye Disease Tear Mediators Unknown status University of Wisconsin, Madison N/A The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Olopatadine Hydrochloride

Condition Name

Condition Name for Olopatadine Hydrochloride
Intervention Trials
Allergic Conjunctivitis 18
Seasonal Allergic Rhinitis 5
Conjunctivitis, Allergic 5
Allergic Rhinitis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Olopatadine Hydrochloride
Intervention Trials
Conjunctivitis, Allergic 27
Conjunctivitis 26
Rhinitis 14
Rhinitis, Allergic 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Olopatadine Hydrochloride

Trials by Country

Trials by Country for Olopatadine Hydrochloride
Location Trials
United States 57
Japan 4
Canada 4
India 2
Croatia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Olopatadine Hydrochloride
Location Trials
Texas 9
Massachusetts 4
Tennessee 3
Wisconsin 3
Illinois 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Olopatadine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Olopatadine Hydrochloride
Clinical Trial Phase Trials
Phase 4 19
Phase 3 13
Phase 2 5
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Olopatadine Hydrochloride
Clinical Trial Phase Trials
Completed 33
Recruiting 3
Withdrawn 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Olopatadine Hydrochloride

Sponsor Name

Sponsor Name for Olopatadine Hydrochloride
Sponsor Trials
Alcon Research 20
Allergan 3
Merck Sharp & Dohme Corp. 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Olopatadine Hydrochloride
Sponsor Trials
Industry 35
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chubb
Colorcon
Express Scripts
Cerilliant
McKesson
Harvard Business School
US Army
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.